10.30.14
Deerland Enzymes’ vice president of technology, John Deaton, Ph.D., along with Theodore Hersh, MD, chief science officer of the alliance with healthcare technology company Thione International, and other members of the Deerland Enzymes research and development team, have authored a new study, “Natural Antimicrobial Compounds in Small Intestinal Bacterial Overgrowth Syndrome” in the peer-reviewed Natural Medicine Journal.
The article explains the effect of specific compounds on the colonic bacteria that are present in small bowel bacterial overgrowth syndrome (SIBOS). Enzymes and other anti-microbial ingredients such as chelators, peptides and essential oils were the focus of the study. “Our aim was to determine the optimal combination of specific enzymes and antimicrobial ingredients in the reduction and suppression of the growth of various SIBOS-causing bacteria,” explained Dr. Deaton.
For more information: www.deerlandenzymes.com
The article explains the effect of specific compounds on the colonic bacteria that are present in small bowel bacterial overgrowth syndrome (SIBOS). Enzymes and other anti-microbial ingredients such as chelators, peptides and essential oils were the focus of the study. “Our aim was to determine the optimal combination of specific enzymes and antimicrobial ingredients in the reduction and suppression of the growth of various SIBOS-causing bacteria,” explained Dr. Deaton.
For more information: www.deerlandenzymes.com